Correction: A New Recombinant BCG Vaccine Induces Specific Th17 and Th1 Effector Cells with Higher Protective Efficacy against Tuberculosis.

Correction: A New Recombinant BCG Vaccine Induces Specific Th17 and Th1 Effector Cells with Higher Protective Efficacy against Tuberculosis.

Bibliographic Details
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4266645

Similar Items

Correction: A New Recombinant BCG Vaccine Induces Specific Th17 and Th1 Effector Cells with Higher Protective Efficacy against Tuberculosis
Published: (2014-01-01)

Commentary: The Role of Neutrophils in the Induction of Specific Th1 and Th17 during Vaccination against Tuberculosis
by: Patricia Méndez-Samperio
Published: (2017-05-01)

Cell wall skeleton of Mycobacterium bovis BCG enhances the vaccine potential of antigen 85B against tuberculosis by inducing Th1 and Th17 responses.
by: Yong Woo Back, et al.
Published: (2019-01-01)

The glycosylated Rv1860 protein of Mycobacterium tuberculosis inhibits dendritic cell mediated TH1 and TH17 polarization of T cells and abrogates protective immunity conferred by BCG.
by: Vijaya Satchidanandam, et al.
Published: (2014-06-01)

Correction: The Glycosylated Rv1860 Protein of Inhibits Dendritic Cell Mediated TH1 and TH17 Polarization of T Cells and Abrogates Protective Immunity Conferred by BCG.
Published: (2014-08-01)

Tuberculosis endemicity and BCG vaccination: Protection against COVID-19
by: Tarun Krishna Boppana, et al.
Published: (2022-06-01)

Effectors of Th1 and Th17 cells act on astrocytes and augment their neuroinflammatory properties
by: Chittappen K. Prajeeth, et al.
Published: (2017-10-01)

Boosting BCG with recombinant influenza A virus tuberculosis vaccines increases pulmonary T cell responses but not protection against Mycobacterium tuberculosis infection.
by: Heni Muflihah, et al.
Published: (2021-01-01)

Cloning of vacll into pnmn013: development of a recombinant bcg vaccine against tuberculosis
by: Ramli, Siti Nur Rasyidah Md
Published: (2004)

Investigating the induction of vaccine-induced Th17 and regulatory T cells in healthy, Mycobacterium bovis BCG-immunized adults vaccinated with a new tuberculosis vaccine, MVA85A.
by: de Cassan, S, et al.
Published: (2010)

Effect of attenuation of Treg during BCG immunization on anti-mycobacterial Th1 responses and protection against Mycobacterium tuberculosis.
by: Barbara Jaron, et al.
Published: (2008-01-01)

Correction: MVA.85A Boosting of BCG and an Attenuated, Deficient Vaccine Both Show Protective Efficacy Against Tuberculosis in Rhesus Macaques.
by: Frank A. W. Verreck, et al.
Published: (2011-01-01)

Th1/Th17 cell induction following vaccination with the novel tuberculosis vaccine MVA85A and their role in Mycobacterium tuberculosis challenge
by: Griffiths, K, et al.
Published: (2011)

Recombinant BCG Expressing LTAK63 Adjuvant induces Superior Protection against Mycobacterium tuberculosis
by: Ivan P. Nascimento, et al.
Published: (2017-05-01)

Investigating the Induction of Vaccine-Induced Th17 and Regulatory T Cells in Healthy, Mycobacterium bovis BCG Immunized Adults Vaccinated with a New Tuberculosis Vaccine, MVA85A (vol 17, pg 1066, 2010)
by: de Cassan, S, et al.
Published: (2011)

Protective Efficacy of BCG Vaccination in Calves Vaccinated at Different Ages
by: Jayne C. Hope, et al.
Published: (2023-05-01)

Field evaluation of the efficacy of Mycobacterium bovis BCG vaccine against tuberculosis in goats
by: Enric Vidal, et al.
Published: (2017-08-01)

The Efficacy of the BCG Vaccine against Newly Emerging Clinical Strains of Mycobacterium tuberculosis.
by: Marcela Henao-Tamayo, et al.
Published: (2015-01-01)

Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis.
by: Matthew Cummings, et al.
Published: (2018-01-01)

BCG vaccine and pulmonary tuberculosis
by: SH Tafreshi
Published: (2017-05-01)

Correction: MVA.85A Boosting of BCG and an Attenuated, phoP Deficient M. tuberculosis Vaccine Both Show Protective Efficacy Against Tuberculosis in Rhesus Macaques
Published: (2011-01-01)

Human immunodeficiency virus infection impairs Th1 and Th17 Mycobacterium tuberculosis–specific T-cell responses
by: Murray, L, et al.
Published: (2018)

Investigating the induction of vaccine-induced Th17 and regulatory T cells in healthy, Mycobacterium bovis BCG immunized adults vaccinated with a new tuberculosis vaccine, MVA85A (Clinical and Vaccine Immunology (2010) 17, 7, (1066-1073))
by: De Cassan, S, et al.
Published: (2011)

Distinct effector memory CD4+ T cell signatures in latent Mycobacterium tuberculosis infection, BCG vaccination and clinically resolved tuberculosis.
by: Toidi Adekambi, et al.
Published: (2012-01-01)

Prediabetes is associated with the modulation of antigen-specific Th1/Tc1 and Th17/Tc17 responses in latent Mycobacterium tuberculosis infection.
by: Nathella Pavan Kumar, et al.
Published: (2017-01-01)

Cytotoxic effector functions of T cells are not required for protective immunity against fatal Rickettsia typhi infection in a murine model of infection: Role of TH1 and TH17 cytokines in protection and pathology.
by: Kristin Moderzynski, et al.
Published: (2017-02-01)

Identification of Mycobacterium tuberculosis-specific Th1, Th17 and Th22 cells using the expression of CD40L in tuberculous pleurisy.
by: Li Li, et al.
Published: (2011-01-01)

Protective efficacy of BCG overexpressing an L,D-transpeptidase against M. tuberculosis infection.
by: Scott T Nolan, et al.
Published: (2010-10-01)

Efficacy and Safety of BCG Vaccine for Control of Tuberculosis in Domestic Livestock and Wildlife
by: Bryce M. Buddle, et al.
Published: (2018-10-01)

BCG vaccination strategies against tuberculosis: updates and perspectives
by: Mengjin Qu, et al.
Published: (2021-12-01)

The metalloprotease ADAM12 regulates the effector function of human Th17 cells.
by: Angela X Zhou, et al.
Published: (2013-01-01)

Vacina BCG contra tuberculose: efeito protetor e políticas de vacinação BCG vaccine against tuberculosis: its protective effect and vaccination policies
by: Susan M Pereira, et al.
Published: (2007-09-01)

Recombinant BCG-LTAK63 Vaccine Candidate for Tuberculosis Induces an Inflammatory Profile in Human Macrophages
by: Carina C. dos Santos, et al.
Published: (2022-05-01)

Multi-stage subunit vaccines against Mycobacterium tuberculosis: an alternative to the BCG vaccine or a BCG-prime boost?
by: Farzad Khademi, et al.
Published: (2018-01-01)

Evidence for a role for interleukin-17, Th17 cells and iron homeostasis in protective immunity against tuberculosis in cynomolgus macaques.
by: Alice S Wareham, et al.
Published: (2014-01-01)

Recombinant BCG vaccine expressing multistage antigens of Mycobacterium tuberculosis provides long-term immunity against tuberculosis in BALB/c mice
by: Danang Fang, et al.
Published: (2024-12-01)

Urban particulate matter–activated human dendritic cells induce the expansion of potent inflammatory Th1, Th2, and Th17 effector cells
by: Matthews, N, et al.
Published: (2016)

A lipidated peptide of Mycobacterium tuberculosis resuscitates the protective efficacy of BCG vaccine by evoking memory T cell immunity
by: Pradeep K. Rai, et al.
Published: (2017-10-01)

Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis.
by: Vordermeier, H, et al.
Published: (2009)

Mucosal BCG Vaccination Induces Protective Lung-Resident Memory T Cell Populations against Tuberculosis
by: Carolina Perdomo, et al.
Published: (2016-12-01)